Search research articles
Contact Us
Filters
Showing results (41-50 of 115) with videos related to
Page
of 12
Sort By:
The International Journal of Neuropsychopharmacology
|
November 8, 2003
Psychotic symptoms in methamphetamine psychotic in-patients
Manit Srisurapanont, Robert Ali, John Marsden, et al.
The Cochrane Database of Systematic Reviews
|
August 12, 2011
Oral substitution treatment of injecting opioid users for prevention of HIV infection
Linda Gowing, Michael F Farrell, Reinhard Bornemann, et al.
Addiction (Abingdon, England)
|
November 1, 2014
Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol
Louisa Degenhardt, Briony Larance, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 1, 2011
Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis
Manit Srisurapanont, Suwanna Arunpongpaisal, Kiyoshi Wada, et al.
The Cochrane Database of Systematic Reviews
|
March 2, 2013
Methadone at tapered doses for the management of opioid withdrawal
Laura Amato, Marina Davoli, Silvia Minozzi, et al.
The International Journal on Drug Policy
|
November 29, 2023
Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022
Chrianna Bharat, Kendal Chidwick, Natasa Gisev, et al.
Drug and Alcohol Dependence
|
July 13, 2014
A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?
Briony Larance, Natacha Carragher, Richard P Mattick, et al.
Addiction (Abingdon, England)
|
January 15, 2008
Exposure to opioid maintenance treatment reduces long-term mortality
Amy Gibson, Louisa Degenhardt, Richard P Mattick, et al.
Drug and Alcohol Review
|
September 3, 2015
The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film
Nancy White, Robert Ali, Briony Larance, et al.
Drug and Alcohol Review
|
September 28, 2020
Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam
Thu Vuong, Alison Ritter, Marian Shanahan, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 115) with videos related to
Sort By:
Page
of 12
The International Journal of Neuropsychopharmacology
|
November 8, 2003
Psychotic symptoms in methamphetamine psychotic in-patients
Manit Srisurapanont, Robert Ali, John Marsden, et al.
The Cochrane Database of Systematic Reviews
|
August 12, 2011
Oral substitution treatment of injecting opioid users for prevention of HIV infection
Linda Gowing, Michael F Farrell, Reinhard Bornemann, et al.
Addiction (Abingdon, England)
|
November 1, 2014
Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol
Louisa Degenhardt, Briony Larance, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 1, 2011
Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis
Manit Srisurapanont, Suwanna Arunpongpaisal, Kiyoshi Wada, et al.
The Cochrane Database of Systematic Reviews
|
March 2, 2013
Methadone at tapered doses for the management of opioid withdrawal
Laura Amato, Marina Davoli, Silvia Minozzi, et al.
The International Journal on Drug Policy
|
November 29, 2023
Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022
Chrianna Bharat, Kendal Chidwick, Natasa Gisev, et al.
Drug and Alcohol Dependence
|
July 13, 2014
A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?
Briony Larance, Natacha Carragher, Richard P Mattick, et al.
Addiction (Abingdon, England)
|
January 15, 2008
Exposure to opioid maintenance treatment reduces long-term mortality
Amy Gibson, Louisa Degenhardt, Richard P Mattick, et al.
Drug and Alcohol Review
|
September 3, 2015
The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film
Nancy White, Robert Ali, Briony Larance, et al.
Drug and Alcohol Review
|
September 28, 2020
Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam
Thu Vuong, Alison Ritter, Marian Shanahan, et al.
Page
of 12